Stock screenerAll disclosures →
EDGAR →
MBX
Conviction 94HealthcareScan · Thu, Jun 25, 2026MBX$50.33+3.99%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 1.08M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price50.33
Change+3.99%
Gap+0.31%
Rel volume1.72×
Avg volume916.79K
Avg $ vol34.72M
SMA 2036.57
SMA 5034.32
SMA 20029.27
Price vs 50+46.64%
Price vs 200+71.96%
MA stackbullish
50/200 cross—
Supertrendup · 40.27
RSI (14)81
MACD hist1.72
MACD crossbull · 9d
Stoch %K / %D92 / 95
ADX (14)32
+DI / −DI39 / 9
RSI divergence—
MACD divergenceBullish
ATR %+6.35%
ADR %8.08%
52w high50.33
52w low9.75
From 52w high+0.00%
Above 52w low+416.47%
New 52w highYes
SqueezeOff
Bollinger width74.64%
%B1.00
Donchian pos91.76%
Donchian high52.34
Donchian low28.00
AVWAP (52w high)50.37
vs AVWAP high-0.08%
AVWAP (52w low)27.58
vs AVWAP low+82.49%
OBV trendUp
Chaikin MF (20)0.38
Today vs 20d1.72×
Avg vol (14d)1.08M
Avg vol (20d)916.79K
Avg $ vol (20d)34.72M
Market cap2.4B
RS 3m (vs SPY)+61.72%
RS 6m (vs SPY)+51.37%
RS line new highYes
Trend template8/8
Technical rank95.6
1 week+21.01%
1 month+58.52%
3 months+73.79%
6 months+44.63%
1 year+355.48%
YTD+64.75%
P/E-27.54
P/B5.47
P/S—
P/FCF-29.26
EPS-2.38
Div yield—
ROE-19.87%
ROA-19.21%
Debt/Eq—
Current30.79
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-40.45%
Price target74.75
Target upside48.52%
Analyst ratingBuy
Institutional115.21%
Ent. value2.35B
Revenue—
Net income-23.52M
Gross profit—
Free cash flow-81.88M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out47.6M
Employees63
ListedFri, Sep 13, 2024
Free float28.64M
Float %60.2%
Short interest4.81M
Days to cover8.5d
Short volume51.4%
Squeeze score77 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.68 · 3 est
Last EPS vs est−$0.51 vs −$0.62
Last surprise+17.7% beat
Setup gradeA+
Conviction94 / 100
Pattern quality—
Tech rank95.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance39.46
Support28.41
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MBX
No recent disclosed trades by Congress in MBX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MBX · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hoerter Steven L. Director · Stock option (right to buy) · 2026-06-04 | Grant | 12.5K | $0 | 2026-06-04 | 2026-06-05 |
Mathers Edward T Director · Stock option (right to buy) · 2026-06-04 | Grant | 12.5K | $0 | 2026-06-04 | 2026-06-05 |
Ryder Steven Director · Stock option (right to buy) · 2026-06-04 | Grant | 12.5K | $0 | 2026-06-04 | 2026-06-05 |
Hoerter Steven L. Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-05 |
Pescovitz Ora H. Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-05 |
Pescovitz Ora H. Director · Stock option (right to buy) · 2026-06-04 | Grant | 12.5K | $0 | 2026-06-04 | 2026-06-05 |
Stelzer Laurie Director · Stock option (right to buy) · 2026-06-04 | Grant | 12.5K | $0 | 2026-06-04 | 2026-06-05 |
Heron Patrick J Director · Stock option (right to buy) · 2026-06-04 | Grant | 12.5K | $0 | 2026-06-04 | 2026-06-05 |
Aynechi Tiba Director · Stock option (right to buy) · 2026-06-04 | Grant | 12.5K | $0 | 2026-06-04 | 2026-06-05 |
Azoulay Salomon Chief Medical Officer · Common Stock · 2026-05-08 | Exercise | 55K | $575K | 2026-05-08 | 2026-05-11 |
SEC filings
EDGAR filings in MBX · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.